| Wenyue Hu |
wen****@vividion.com
|
Vividion Therapeutics, Inc. |
VP head of toxicology |
Biotechnology |
San Diego, CA, US |
|
| David Weinstein |
dav***@vividion.com
|
Vividion Therapeutics, Inc. |
Vice President, Head of Chemistry |
Biotechnology |
San Diego, CA, US |
|
| Gerry Hernandez |
ger***@vividion.com
|
Vividion Therapeutics, Inc. |
VP of Finance |
Biotechnology |
San Diego, CA, US |
|
| Maurice Marsini |
mau*****@vividion.com
|
Vividion Therapeutics, Inc. |
Vice President, Head of CMC |
Biotechnology |
San Diego, CA, US |
|
| Gabriel Simon |
gab*****@vividion.com
|
Vividion Therapeutics, Inc. |
Vice President, Head of Early Discovery and Enabling Technologies |
Biotechnology |
San Diego, CA, US |
|
| David Eveleth |
dev*****@trefoiltherapeutics.com
|
trefoiltherapeutics.com |
President, CEO and Founder |
|
San Diego, CA, US |
|
| Mark Cpi |
mcp*@trefoiltherapeutics.com
|
trefoiltherapeutics.com |
Chief Medical Officer |
|
Boulder, CO, US |
|
| Thomas Tremblay |
ttr******@trefoiltherapeutics.com
|
trefoiltherapeutics.com |
Vice President, Clinical Development |
|
San Francisco, CA, US |
|
| Kenneth Thomas |
kth****@trefoiltherapeutics.com
|
trefoiltherapeutics.com |
Co-founder |
|
Chatham, NJ, US |
|
| Jody LaPar |
jla***@trefoiltherapeutics.com
|
trefoiltherapeutics.com |
Senior Director Clinical Operations |
|
Boulder, CO, US |
|